Healixia webinar: ‘Most Favored Nation’ Executive Order: Impact on Belgian Medicines Access?
Please join us for this Webinar and learn about the following:
- Why did the Trump Administration launch this measure
- How will this look in practice?
- What are the expected consequences for Medicines Access in the EU and Belgium in particular?
We are excited to present the following speakers on this topic:
- Justin McCarthy, DGA – Washington Office
- Prof. Walter Van Dyck, VBS Vlerick Business School (panel debate)
- Karel Joos, DGA – Brussels Office (panel debate)
The session will be moderated by Marjan Willaert and Sven Tops from the Healixia Market Access Education Group.